Rundell K, Shuster C W
J Bacteriol. 1975 Sep;123(3):928-36. doi: 10.1128/jb.123.3.928-936.1975.
Both the synthesis of lipopolysaccharide O-antigen and the synthesis of peptidoglycan in Salmonella typhimurium proceed via membrane-bound glycosylated lipid intermediates. The first enzyme of each pathway transfers a sugar phosphate from a nucleotide sugar to the glycosyl carrier lipid (P-GCL). Each enzyme catalyzes an exchange reaction between the reaction product urine monophosphate, and the nucleotide sugar substrate. Several strains of S. typhimurium defective in lipopolysaccharide synthesis accumulate glycosylated lipid intermediates under appropriate conditions. In addition, strains lysogenic for phage P22 synthesize a glucose derivative of the carrier lipid. These strains were used to demonstrate the P/GCL requirement of the exchange reaction catalyzed by galactose-diphosphoglycosyl carrier lipid (GCL-PP-Gal) synthetase, the first enzyme of O-antigen synthesis. Enzyme activity is greatly reduced when glycosylated P-GCL accumulates on the cytoplasmic membrane. The exchange reaction catalyzed by the first enzyme of peptidoglycan synthesis is unaffected by the accumulation of O-antigen fragments on the carrier lipid and may interact with a different pool of P-GCL within the membrane. GCL-PP-Gal synthetase activity cannot be detected in the membranes of two rfa mutants that synthesize incomplete lipopolysaccharide core. Either the synthesis of GCL-PP-Gal synthetase or the stable integration of the enzyme into the membrane structure may be disrupted in the rfa mutants. Peptidoglycan synthesis is unaffected by the mutations affecting the core glycosyltransferases.
鼠伤寒沙门氏菌中脂多糖O抗原的合成与肽聚糖的合成均通过膜结合糖基化脂质中间体进行。每条途径的第一种酶将磷酸糖从核苷酸糖转移至糖基载体脂质(P-GCL)。每种酶都催化反应产物尿单磷酸与核苷酸糖底物之间的交换反应。几种脂多糖合成缺陷的鼠伤寒沙门氏菌菌株在适当条件下会积累糖基化脂质中间体。此外,携带噬菌体P22的溶原性菌株会合成载体脂质的葡萄糖衍生物。这些菌株被用于证明由O抗原合成的第一种酶——半乳糖二磷酸糖基载体脂质(GCL-PP-Gal)合成酶催化的交换反应对P/GCL的需求。当糖基化的P-GCL在细胞质膜上积累时,酶活性会大大降低。肽聚糖合成的第一种酶催化的交换反应不受载体脂质上O抗原片段积累的影响,可能与膜内不同的P-GCL池相互作用。在合成不完整脂多糖核心的两个rfa突变体的膜中无法检测到GCL-PP-Gal合成酶活性。rfa突变体中可能会破坏GCL-PP-Gal合成酶的合成或该酶在膜结构中的稳定整合。影响核心糖基转移酶的突变不会影响肽聚糖的合成。